Description of the cohort
Between December 2021 and February 2025, a total of 103 participants were recruited, and preoperative morning serum samples were collected (Fig. 1). Among them, 47 (45.6%) had ovarian cancer, including 42 (89.4%) with…
A novel serum-based steroid-protein panels for differentiating ovarian cancer from non-malignant adnexal masses | Cancer Cell International
